Metrion Biosciences in a £3.5M led by Maven Capital Partners, alongside Gresham House Ventures
10 December 2023
10 December 2023
Total investments received (USD): 8.15m
Round value (USD): 4.34m
Company: Metrion Biosciences
Related deals
Fuse Diagnostics raises £1.6 million seed funding from a syndicate of angel investors and innovation agency Innovate UK.
Investments
02 May 2024
Monument Therapeutics completed a £1.0 million fundraise with investors led by Cambridge Angels, joined by the Manchester Angels and SyndicateRoom
Investments
13 April 2024
Neupulse raised $3.2M in a seed funding round led by Eos Advisory
Investments
15 March 2024
Senisca raised £3.7m with Emerging Longevity Ventures, QantX, R42 Group, Trend Investment Group, Apex Ventures and Lifespan Vision Ventures.
Investments
08 March 2024
Newcells Biotech raised £2.4m in funding from investors including North East Venture Fund, Mercia Ventures and Northstar Ventures.
Investments
03 February 2024
Belgium
Netherlands
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain